Pay Less, Gain More: APP Tops Synopsys Stock
APP is Synopsys’s peer in Application Software industry that has:
1) Lower valuation (P/OpInc) compared to Synopsys stock
2) But higher revenue and operating income growth
This disconnect between valuation and performance could mean that you are better off buying APP stock vs. SNPS stock
Ask yourself – Is holding SNPS stock risky? Of course it is. High Quality Portfolio mitigates that risk.
- Apple Stock Hands $847 Bil Back – Worth a Look?
- Home Depot Stock Pays Out $129 Bil – Investors Take Note
- Ten-Year Tally: Verizon Communications Stock Delivers $103 Bil Gain
- Has Adobe Stock Quietly Become a Value Opportunity?
- Could Cash Machine Adobe Stock Be Your Next Buy?
- AeroVironment Stock To $232?
Key Metrics Compared
| Metric | SNPS | APP |
|---|---|---|
| P/OpInc* | 104.0x | 55.0x |
| LTM OpInc Growth | -32.5% | 127.8% |
| 3Y Avg OpInc Growth | -5.3% | 477.0% |
| LTM Revenue Growth | 15.1% | 86.4% |
| 3Y Avg Revenue Growth | 15.2% | 36.0% |
OpInc = Operating Income, P/OpInc = Price To Operating Income Ratio
But do these numbers tell the full story? Read Buy or Sell SNPS Stock to see if Synopsys still has an edge that holds up under the hood. As a quick background, Synopsys (SNPS) provides electronic design automation software and intellectual property solutions for integrated circuits, supporting USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications.
This is just one approach to evaluate investments. Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risk while giving upside exposure
Is The Mismatch In Stock Price Temporary
One way to check if Synopsys stock is expensive now versus the other tickers would be to see how these metrics compared across companies exactly a year ago. Specifically, if there has been a marked reversal in the trend for Synopsys in the last 12 months, then there is a chance that the current mismatch is likely to reverse. On the other hand, a persistent underperformance in revenue and operating income growth for Synopsys would reinforce the conclusion that the stock is expensive compared to its peers, but may not revert soon
Key Metrics Compared 1 Yr Prior
| Metric | SNPS | APP |
|---|---|---|
| P/OpInc* | 76.8x | 39x |
| LTM OpInc Growth | -24.8% | 148.8% |
| 3Y Avg OpInc Growth | 0.9% | 414.8% |
| LTM Revenue Growth | 8.0% | 69.0% |
| 3Y Avg Revenue Growth | 9.7% | 30.7% |
OpInc = Operating Income
Additional Metrics To Consider
| Metric | SNPS | APP |
|---|---|---|
| P/S | 13.5x | 28.9x |
| Market Cap (Current) | $ 95.1 Bil | $ 191.4 Bil |
| LTM Revenue | $ 7.05 Bil | $ 6.63 Bil |
| LTM Opinc | $ 914.93 Mil | $ 3.48 Bil |
| LTM Op Margin | 13.0% | 52.5% |
OpInc = Operating Income
Alternate buying based on valuation, while attractive, needs to be evaluated carefully from multiple angles. Such multi-factor analysis is exactly how we construct Trefis portfolio strategies. If you want upside with a smoother ride than an individual stock, consider the High Quality portfolio, which has outperformed the its benchmark – a combination of S&P 500, Russell, and S&P midcap index.